Wound Care Market

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen, Alginate), Devices (NPWT, Debridement), Grafts, Matrices, Topical Agents, Sutures, Stapler), Wound (Traumatic, Diabetic Ulcers, Surgical, Burn), End User - Global Forecast to 2026

Report Code: MD 2611 Apr, 2021, by marketsandmarkets.com

[268 Pages Report] The global wound care market is projected to reach USD 27.8 billion by 2026 from USD 19.3 billion in 2021, at a CAGR of 7.6% during the forecast period. Market growth is largely driven by factors such as the growing prevalence of chronic conditions resulting in chronic, surgical, acute, and traumatic wounds; increasing spending on chronic wounds; rising use of regenerative medicine in wound management; and technological advancements. The high growth potential of emerging economies and the growing number of acquisitions by key players have also opened an array of opportunities for the growth of the wound care market.

Wound Care Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on Global Wound care market

The COVID-19 outbreak will impact the wound care market in the initial phase of the forecast period. Due to nationwide lockdowns, denied wound care services, canceled or postponed elective surgeries, and increasing skin injuries in COVID-19 medical care providers; the wound care market is expected to register a certain decline during the forecast period. However, during the latter half of the forecast period, the demand for wound care products is expected to rise drastically.

Market Dynamics

Driver: Growing prevalence of diseases & conditions affecting wound healing capabilities

Physical health conditions, such as acute wounds, chronic wounds, and surgical wounds, have a negative effect on the wound healing process. The prevalence of acute, chronic, and surgical wounds has increased significantly over the past decade, primarily due to the growing global geriatric population, rising traumatic wounds, increasing number of surgeries, and the increasing prevalence of conditions like obesity and diabetes. Diabetes and obesity can result in an increased overall incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and chronic wounds, which require treatments (wound management) and incur exorbitant medical expenses.

Restraint: High cost of advanced wound care products

The high cost of chronic wound treatments and advanced wound care products may negatively affect their adoption, especially in cost-sensitive markets such as Asia and the RoW. Patients and physicians in these regions opt for less-expensive wound care products. Although there are many bioengineered dressings available in these markets, physicians and patients tend to opt for traditional and basic wound care products due to their low costs.

Opportunity: Growth potential in emerging economies

Compared to Europe and North America, the Asia Pacific and Latin America are relatively untapped markets for wound management and have huge growth potential. Owing to this, various players are focusing on increasing their presence in these regions. The large patient pool and the rising geriatric population in emerging countries offer significant growth opportunities for players in the wound care market.

“Advanced wound care products segment accounted for the largest share of the wound care market, by product, in 2020”

Based on products, the wound care market is segmented into advanced wound care products, surgical wound care products, and traditional wound care products. In 2020, the advanced wound care products segment accounted for the largest market share. Advanced wound care products are increasingly being used as the first line of therapy, making it likely that they will cannibalize the share of the traditional wound care products market. The advantages of advanced wound care over traditional wound care are the key factors driving the growth of this market.

“Hospitals & Clinics segment accounted for the largest share in the market, by end user, in 2020

Based on end users, the wound care market is segmented into hospitals & clinics, long-term care facilities, home care settings, and other end users. In 2020, the hospitals & clinics segment accounted for the largest share in the global wound care market. The large share of this segment can be attributed to factors such as the growing prevalence of surgical and chronic wounds; rising incidence of associated SSIs and HAIs; and the increasing incidence of burn injuries.

“North America is the largest regional market for wound care market”

The global wound care market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. The wound care market is dominated by developed countries across North America and Europe in the global market in 2020. In 2020, North America accounted for the largest market share, in 2020. The large share of this regional segment can be attributed to the growing prevalence of chronic conditions resulting in chronic, surgical, and traumatic wounds; the increasing incidence of burn injuries; increasing spending on surgical and chronic wounds; and technological advancements in this region.

Wound Care Market  by Region

To know about the assumptions considered for the study, download the pdf brochure

Some key players in the wound care market (2021 - 2026)

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2019–2026

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

Product, wound type, end user, and region

Geographies covered

North America, Europe, Asia Pacific, Latin America, & Middle East & Africa

Companies covered

Smith & Nephew Plc. (UK), Mölnlycke Health Care AB (Sweden), Baxter International (US), 3M Company (US), Integra LifeSciences Holdings Corporation (US), ConvaTec Group Plc (UK), Coloplast A/S (Denmark), Medtronic Plc (Ireland), Ethicon Inc. (US), PAUL HARTMANN AG (Germany), MiMedx Group (US), DeRoyal Industries (US), Organogenesis Holdings (US), Kerecis (Iceland), ACell (US), Lohmann & Rauscher International GmbH & Co. (Germany), Medela AG (Switzerland), Talley Group (England), Pensar Medical (US), B. Braun Melsungen AG (Germany), Cardinal Health Inc. (US), Misonix (US), Zimmer Biomet Holdings (US), DermaRite Industries (US), Medline Industries (US), Advancis Medical LLC (UK), MilLaboratories Pvt. Ltd. (India), Welcare Industries Spa. (Italy), Wuhan VSD Medical Science & Technology (China), and Haromed BVBA (Belgium).

This report categorizes the wound care market into the following segments and subsegments:

By Product

  • Advanced Wound Care Products
    • Advanced Dressings
      • Foam Dressings
        • Silicone Dressings
        • Non- Silicone Dressings
      • Hydrocolloid Dressings
      • Film Dressings
      • Alginate Dressings
      • Hydrogel Dressings
      • Collagen Dressings
      • Hydrofiber Dressings
      • Wound Contact Layers
      • Superabsorbent Dressings
      • Other Advanced Dressings
    • Wound Therapy Devices
      • Debridement Devices & Accessories
      • Wound Assessment & Monitoring Devices
      • Portable & Conventional NPWT Devices
      • Other Devices & Accessories
    • Grafts & Matrices
    • Topical Agents
  • Surgical Wound Care Products
    • Sutures
    • Staplers
    • Tissue Adhesives, Sealants, & Glues
      • Fibrin-based Sealants
      • Collagen-based Sealants
      • Synthetic Adhesives
  • Traditional Wound Care Products

By Wound Type

  • Surgical & Traumatic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Burns & Other Wounds

By End User

  • Hospitals & Clinics
    • Inpatient Settings
    • Outpatient Settings
  • Long-term Care Settings
  • Home Care Settings
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Singapore
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In August 2020, Smith & Nephew Plc. (UK) launched ARIA.
  • In February 2020, Integra LifeSciences Holdings Corporation (Sweden) launched AmnioExcel Plus Placental Allograft Membrane.
  • In February 2020, Baxter International (US) acquired Sanofi S.A (France).

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           FIGURE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 STAKEHOLDERS
    1.6 LIMITATIONS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 34)
    2.1 RESEARCH DATA
    2.2 RESEARCH APPROACH
           FIGURE 2 RESEARCH DESIGN
           2.2.1 SECONDARY DATA
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Key industry insights
                               FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,  AND REGION
    2.3 MARKET SIZE ESTIMATION
           2.3.1 BOTTOM-UP APPROACH
                    2.3.1.1 Segmental revenue estimation approach
                               FIGURE 4 BOTTOM-UP APPROACH: SEGMENTAL REVENUE ESTIMATION APPROACH
                    2.3.1.2 Company revenue estimation approach
                               FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
                    2.3.1.3 CAGR projections
                               FIGURE 6 SUPPLY-SIDE ANALYSIS
           2.3.2 TOP-DOWN APPROACH
                    FIGURE 7 WOUND CARE MARKET: TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 COVID-19 HEALTH ASSESSMENT
    2.7 COVID-19 ECONOMIC ASSESSMENT
    2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
           FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
           FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
    2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE WOUND CARE MARKET

3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 11 WOUND CARE MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    FIGURE 12 WOUND CARE MARKET, BY WOUND TYPE, 2021 VS. 2026 (USD MILLION)
    FIGURE 13 WOUND CARE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    FIGURE 14 WOUND CARE MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 49)
    4.1 WOUND CARE MARKET OVERVIEW
           FIGURE 15 INCREASING DEMAND FOR ADVANCED WOUND PRODUCTS TO DRIVE MARKET GROWTH
    4.2 ADVANCED WOUND DRESSINGS MARKET,  BY TYPE, 2021 VS. 2026 (USD MILLION)
           FIGURE 16 FOAM DRESSINGS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2020
    4.3 WOUND CARE MARKET FOR HOSPITALS & CLINICS,  BY TYPE, 2021 VS. 2026
           FIGURE 17 INPATIENT SETTINGS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
    4.4 WOUND CARE MARKET, BY REGION (2021−2026)
           FIGURE 18 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 52)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 19 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
           5.2.1 DRIVERS
                    5.2.1.1 Growing prevalence of diseases & conditions affecting wound healing capabilities
                               5.2.1.1.1 Growing geriatric population
                               5.2.1.1.2 Increasing prevalence of diabetes
                                             FIGURE 20 INCIDENCE OF DIABETES, BY REGION, 2015 VS. 2040 (MILLION CASES)
                               5.2.1.1.3 High incidence of obesity
                               5.2.1.1.4 Increasing number of surgical procedures across the globe
                                             TABLE 1 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
                               5.2.1.1.5 Increasing number of traumatic wounds
                    5.2.1.2 Increasing spending on chronic wounds
                    5.2.1.3 Technological advancements
                    5.2.1.4 Rising use of regenerative medicine in wound management
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of advanced wound care products
                    5.2.2.2 Risks associated with the use of advanced wound care products
                               TABLE 2 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth potential in emerging economies
                               TABLE 3 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC
           5.2.4 TRENDS
                    5.2.4.1 Acquisitions by leading companies in the market
                    5.2.4.2 Focus on expanding the capabilities of current technologies and launching novel products
                               5.2.4.2.1 Smart advanced wound care
                               5.2.4.2.2 Color changing dressings
                               5.2.4.2.3 Integration of nanotechnology in wound care products
                               5.2.4.2.4 Novel wound assessment/measurement devices
    5.3 IMPACT OF COVID-19 ON THE WOUND CARE MARKET
    5.4 ECOSYSTEM ANALYSIS
           FIGURE 21 WOUND CARE MARKET: ECOSYSTEM ANALYSIS
    5.5 VALUE CHAIN ANALYSIS
           FIGURE 22 WOUND CARE MARKET: VALUE CHAIN ANALYSIS OVERVIEW
           5.5.1 WOUND CARE MARKET: PROCESS-BASED VALUE CHAIN ANALYSIS
    5.6 SUPPLY CHAIN ANALYSIS
           FIGURE 23 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS
    5.7 PATENT ANALYSIS
           FIGURE 24 WOUND CARE MARKET: PATENT ANALYSIS
    5.8 PRICING ANALYSIS
           TABLE 4 PRICES OF WOUND CARE PRODUCTS (2021)
    5.9 PESTEL ANALYSIS
           FIGURE 25 WOUND CARE MARKET: PESTEL ANALYSIS
    5.10 PORTER’S FIVE FORCES ANALYSIS
           5.10.1 THREAT FROM NEW ENTRANTS
           5.10.2 THREAT FROM SUBSTITUTES
           5.10.3 BARGAINING POWER OF BUYERS
           5.10.4 BARGAINING POWER OF SUPPLIERS
           5.10.5 INTENSITY OF COMPETITIVE RIVALRY
    5.11 TRADE ANALYSIS
           5.11.1 TRADE ANALYSIS FOR SUTURES AND ADHESIVES
                    TABLE 5 IMPORT DATA FOR SUTURES & ADHESIVES, BY COUNTRY, 2016–2020 (USD THOUSAND)
                    TABLE 6 IMPORT DATA FOR SUTURES & ADHESIVES, BY COUNTRY, 2016–2020 (TONS)
    5.12 REGULATORY GUIDELINES
           5.12.1 NORTH AMERICA
           5.12.2 EUROPE
           5.12.3 EMERGING MARKETS
    5.13 YC – YCC SHIFT
                    FIGURE 26 YC – YCC SHIFT FOR THE WOUND CARE MARKET
    5.14 MARKET DISRUPTION

6 WOUND CARE MARKET, BY PRODUCT (Page No. - 73)
    6.1 INTRODUCTION
           TABLE 7 WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
    6.2 ADVANCED WOUND CARE PRODUCTS
           TABLE 8 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 9 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           6.2.1 ADVANCED WOUND DRESSINGS
                    TABLE 10 ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 11 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    6.2.1.1 Foam dressings
                               TABLE 12 FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                               TABLE 13 FOAM DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.2.1.1.1 Silicone dressings
                                             6.2.1.1.1.1 Silicone dressings are used for a large variety of wounds—a key factor driving market growth
                                                TABLE 14 SILICONE DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                               6.2.1.1.2 Non-silicone dressings
                                             6.2.1.1.2.1 Non-silicone dressings are very effective in scar removal and wound healing—a key factor driving market growth
                                                TABLE 15 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.2 Hydrocolloid dressings
                               6.2.1.2.1 Hydrocolloid dressings are cost-effective and promote a moist environment, which is a requirement for optimal healing
                                             TABLE 16 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.3 Film dressings
                               6.2.1.3.1 Non-absorbable nature of film dressings may limit their adoption to a certain extent
                                             TABLE 17 FILM DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.4 Alginate dressings
                               6.2.1.4.1 Alginate dressings are well-suited for pressure and diabetic foot ulcers
                                             TABLE 18 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.5 Hydrogel dressings
                               6.2.1.5.1 Hydrogel dressings are available in several forms for effective use
                                             TABLE 19 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.6 Collagen dressings
                               6.2.1.6.1 Favorable reimbursement scenario for collagen dressings is supporting the growth of this segment
                                             TABLE 20 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.7 Hydrofiber dressings
                               6.2.1.7.1 Hydrofiber dressings combine the properties of hydrocolloids and alginates
                                             TABLE 21 HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.8 Wound contact layers
                               6.2.1.8.1 Wound contact layers protect wound beds from bacterial and fungal growth
                                             TABLE 22 WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.9 Superabsorbent dressings
                               6.2.1.9.1 Superabsorbent dressings are used where adhesive dressings may cause damage
                                             TABLE 23 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.1.10 Other advanced dressings
                               TABLE 24 OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.2 WOUND THERAPY DEVICES
                    TABLE 25 WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 26 WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    6.2.2.1 Portable & conventional NPWT devices
                               6.2.2.1.1 Growing adoption of single-use NPWT devices in homecare will drive market growth
                                             TABLE 27 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.2 Debridement devices & accessories
                               6.2.2.2.1 Development of novel technologies to support market growth
                                             TABLE 28 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.2.2.3 Wound assessment & monitoring devices
                               6.2.2.3.1 Potential cost-reducing capabilities of wound assessment and monitoring devices will boost their adoption
                                             TABLE 29 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION,  2019–2026 (USD MILLION)
                    6.2.2.4 Other devices & accessories
                               TABLE 30 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.3 GRAFTS & MATRICES
                    6.2.3.1 Grafts & matrices promote healing and wound closure
                               TABLE 31 GRAFTS & MATRICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.2.4 TOPICAL AGENTS
                    6.2.4.1 Cost-effectiveness and ease of use in home care settings will drive the demand for topical agents
                               TABLE 32 TOPICAL AGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3 SURGICAL WOUND CARE PRODUCTS
           TABLE 33 SURGICAL WOUND CARE PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
           TABLE 34 SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           6.3.1 SUTURES
                    6.3.1.1 Increasing number of surgical procedures and the high tensile strength afforded by sutures are key factors driving product adoption
                               TABLE 35 SUTURES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.2 STAPLERS
                    6.3.2.1 Staplers are considered to be more accurate than suturing and less likely to allow leakage, resulting in higher product adoption
                               TABLE 36 STAPLERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.3.3 TISSUE ADHESIVES, SEALANTS, AND GLUES
                    TABLE 37 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    TABLE 38 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE,  2019–2026 (USD MILLION)
                    6.3.3.1 Fibrin-based sealants
                               6.3.3.1.1 Fibrin-based sealants provide better results than sutures, which has driven product demand
                                             TABLE 39 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.3.2 Collagen-based sealants
                               6.3.3.2.1 Collagen-based products are used in surgical procedures as an adjunctive to hemostatic agents
                                             TABLE 40 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
                    6.3.3.3 Synthetic adhesives
                               6.3.3.3.1 Synthetics have additional sealing properties than traditional staples—a key driving factor
                                             TABLE 41 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.4 TRADITIONAL WOUND CARE PRODUCTS
           TABLE 42 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
           TABLE 43 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.1 MEDICAL TAPES
                    6.4.1.1 Latex-free tapes are gentle to the skin and hypoallergenic for sensitive patients—key advantages leading to high adoption of these products
                               TABLE 44 MEDICAL TAPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.2 DRESSINGS
                    6.4.2.1 Presence of a large patient population for pressure ulcers (in which dry dressings are extensively used) has ensured a sustained demand for these products
                               TABLE 45 DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           6.4.3 CLEANSING AGENTS
                    6.4.3.1 High risk of HAIs from open wounds will drive the market for cleansing agents
                               TABLE 46 TYPES OF CLEANSING AGENTS
                               TABLE 47 CLEANSING AGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 WOUND CARE MARKET, BY WOUND TYPE (Page No. - 117)
    7.1 INTRODUCTION
           TABLE 48 WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
    7.2 SURGICAL & TRAUMATIC WOUNDS
           7.2.1 RISING VOLUME OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
                    TABLE 49 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY,  2019–2026 (USD MILLION)
    7.3 DIABETIC FOOT ULCERS
           7.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH
                    TABLE 50 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.4 PRESSURE ULCERS
           7.4.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
                    TABLE 51 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2019–2026 (USD MILLION)
    7.5 VENOUS LEG ULCERS
           7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE MARKET GROWTH
                    TABLE 52 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY,  2019–2026 (USD MILLION)
    7.6 BURNS & OTHER WOUNDS
           7.6.1 HIGH INCIDENCE OF BURN INJURIES IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH
                    TABLE 53 WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY,  2019–2026 (USD MILLION)

8 WOUND CARE MARKET, BY END USER (Page No. - 126)
    8.1 INTRODUCTION
           TABLE 54 WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
    8.2 HOSPITALS & CLINICS
           TABLE 55 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 56 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2019–2026 (USD MILLION)
           8.2.1 INPATIENT SETTINGS
                    8.2.1.1 Increasing hospital admissions due to chronic wounds and the rising incidence of hospital-acquired pressure ulcers are key drivers for the growth of this end-user segment
                               TABLE 57 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY,   2019–2026 (USD MILLION)
           8.2.2 OUTPATIENT SETTINGS
                    8.2.2.1 Increasing costs of inpatient care have shifted attention toward outpatient settings
                               TABLE 58 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION)
    8.3 HOME CARE SETTINGS
           8.3.1 DECREASED COSTS AND HIGHER CONVENIENCE AND COMFORT OF HOME CARE WILL ENSURE MARKET GROWTH IN THIS SEGMENT
                    TABLE 59 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY,  2019–2026 (USD MILLION)
    8.4 LONG-TERM CARE FACILITIES
           8.4.1 GROWTH IN THE GERIATRIC AND VULNERABLE POPULATIONS IS DRIVING THE DEMAND FOR BETTER LONG-TERM CARE
                    TABLE 60 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY,  2019–2026 (USD MILLION)
    8.5 OTHER END USERS
           TABLE 61 WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 WOUND CARE MARKET, BY REGION (Page No. - 135)
    9.1 INTRODUCTION
           TABLE 62 WOUND CARE MARKET, BY REGION, 2019–2026 (USD MILLION)
    9.2 NORTH AMERICA
           FIGURE 27 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT
           TABLE 63 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
           TABLE 64 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT,  2019–2026 (USD MILLION)
           TABLE 65 NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Rising incidence of chronic diseases and diabetes is a major driver for the growth of the wound care market in the US
                               TABLE 66 US: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 67 US: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Rising prevalence of diabetes to drive the growth of the wound care market in Canada
                               TABLE 68 INCIDENCE OF DIABETES IN CANADA, 2019 VS. 2029
                               TABLE 69 CANADA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 70 CANADA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.3 EUROPE
           TABLE 71 PREVALENCE OF DIABETES IN EUROPE, 2019 VS. 2045
           TABLE 72 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 73 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 74 EUROPE: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Large diabetic population has supported product development and commercialization efforts in Germany
                               TABLE 75 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 76 GERMANY: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Increase in R&D activities to propel market growth in the UK
                               TABLE 77 UK: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 78 UK: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Growing geriatric population to drive market growth
                               TABLE 79 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 80 FRANCE: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.4 RUSSIA
                    9.3.4.1 Government focus on increasing diabetes awareness will favor market growth in Russia
                               TABLE 81 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 82 RUSSIA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.5 ITALY
                    9.3.5.1 Growth in this market is driven by the improving quality and accessibility to medical care and technologies
                               TABLE 83 ITALY: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 84 ITALY: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.6 SPAIN
                    9.3.6.1 Increasing life expectancies and the growing geriatric population will favor product demand in Spain
                               TABLE 85 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 86 SPAIN: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.3.7 REST OF EUROPE
                    TABLE 87 ROE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 88 ROE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 89 ROE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 90 ROE: FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 91 ROE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 92 ROE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,  2019–2026 (USD MILLION)
                    TABLE 93 ROE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 94 ROE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,  2019–2026 (USD MILLION)
                    TABLE 95 ROE: WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
                    TABLE 96 ROE: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.4 ASIA PACIFIC
           FIGURE 28 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT
           TABLE 97 APAC: WOUND CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 98 APAC: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
           TABLE 99 APAC: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Rising incidence of diabetes to drive the market growth
                               TABLE 100 CHINA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 101 CHINA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Favorable regulations in Japan have resulted in increased product launches and commercialization
                               TABLE 102 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 103 JAPAN: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Investments by international firms have supported market growth in India
                               TABLE 104 INDIA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 105 INDIA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Growing awareness of diabetes management will support market growth in Australia
                               TABLE 106 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 107 AUSTRALIA: WOUND CARE MARKET, BY END USER,  2019–2026 (USD MILLION)
           9.4.5 SOUTH KOREA
                    9.4.5.1 Local manufacturers in South Korea are partnering with research organizations for product development
                               TABLE 108 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 109 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.4.6 SINGAPORE
                    9.4.6.1 Growing prevalence of diabetes is a major driver for the growth of the wound care market in Singapore
                               TABLE 110 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 111 SINGAPORE: WOUND CARE MARKET, BY END USER,  2019–2026 (USD MILLION)
           9.4.7 REST OF ASIA PACIFIC
                    TABLE 112 ROAPAC: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 113 ROAPAC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 114 ROAPAC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 115 ROAPAC: FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 116 ROAPAC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 117 ROAPAC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 118 ROAPAC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE,  2019–2026 (USD MILLION)
                    TABLE 119 ROAPAC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 120 ROAPAC: WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
                    TABLE 121 ROAPAC: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.5 LATIN AMERICA
           TABLE 122 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
           TABLE 123 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT,  2019–2026 (USD MILLION)
           TABLE 124 LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Brazil is one of the largest markets for healthcare in the Latin American region
                               TABLE 125 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 126 BRAZIL: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico
                               TABLE 127 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                               TABLE 128 MEXICO: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                    TABLE 129 ROLATAM: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 130 ROLATAM: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,  2019–2026 (USD MILLION)
                    TABLE 131 ROLATAM: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 132 ROLATAM: FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 133 ROLATAM: WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 134 ROLATAM: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 135 ROLATAM: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE,  2019–2026 (USD MILLION)
                    TABLE 136 ROLATAM: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
                    TABLE 137 ROLATAM: WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
                    TABLE 138 ROLATAM: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA
           9.6.1 RISING PREVALENCE OF CONDITIONS SUCH AS LEG ULCERS IS A POSITIVE INDICATOR FOR MARKET GROWTH
                    TABLE 139 MEA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
                    TABLE 140 MEA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 177)
     10.1 OVERVIEW
               FIGURE 29 KEY STRATEGIES IN THE WOUND CARE MARKET (JANUARY 2018–FEBRUARY 2021)
     10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
               FIGURE 30 REVENUE SHARE ANALYSIS, BY KEY PLAYER, 2020
     10.3 MARKET SHARE ANALYSIS
             10.3.1 ADVANCED WOUND CARE MARKET SHARE ANALYSIS
                       FIGURE 31 ADVANCED WOUND CARE MARKET SHARE, BY KEY PLAYER, 2020
             10.3.2 NEGATIVE PRESSURE WOUND THERAPY (NPWT) MARKET SHARE ANALYSIS
                       FIGURE 32 NPWT MARKET SHARE, BY KEY PLAYER, 2020
             10.3.3 ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS
                       FIGURE 33 ADVANCED WOUND DRESSINGS MARKET SHARE, BY KEY PLAYER, 2020
             10.3.4 SURGICAL SUTURES MARKET SHARE ANALYSIS
                       FIGURE 34 SURGICAL SUTURES MARKET SHARE, BY KEY PLAYER, 2020
             10.3.5 DEBRIDEMENT DEVICES MARKET SHARE ANALYSIS
                       FIGURE 35 DEBRIDEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020
             10.3.6 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET SHARE RANKING
                       TABLE 141 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET SHARE RANKING,  BY COMPANY, 2020
     10.4 COMPANY EVALUATION QUADRANT
             10.4.1 DEFINITION AND METHODOLOGY
             10.4.2 LIST OF EVALUATED VENDORS
                       10.4.2.1 Stars
                       10.4.2.2 Emerging leaders
                       10.4.2.3 Pervasive players
                       10.4.2.4 Participants
                                   FIGURE 36 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
     10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
             10.5.1 PROGRESSIVE COMPANIES
             10.5.2 RESPONSIVE COMPANIES
             10.5.3 STARTING BLOCKS
             10.5.4 DYNAMIC COMPANIES
                       FIGURE 37 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2020
     10.6 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS
               FIGURE 38 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
     10.7 COMPETITIVE SCENARIO
             10.7.1 MARKET EVALUATION FRAMEWORK,  JANUARY 2018–FEBRUARY 2021
             10.7.2 PRODUCT LAUNCHES & APPROVALS
                       TABLE 142 PRODUCT LAUNCHES & APPROVALS (JANUARY 2018–FEBRUARY 2021)
             10.7.3 DEALS
                       TABLE 143 DEALS (JANUARY 2018–FEBRUARY 2021)
             10.7.4 OTHER DEVELOPMENTS
                       TABLE 144 OTHER DEVELOPMENTS (JANUARY 2018–FEBRUARY 2021)

11 COMPANY PROFILES (Page No. - 190)
     11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, SWOT Analysis and Right to Win)*
             11.1.1 3M COMPANY
                       TABLE 145 3M COMPANY: BUSINESS OVERVIEW
                       FIGURE 39 3M COMPANY: COMPANY SNAPSHOT (2020)
             11.1.2 SMITH & NEPHEW PLC
                       TABLE 146 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
                       FIGURE 40 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
             11.1.3 CARDINAL HEALTH
                       TABLE 147 CARDINAL HEALTH: BUSINESS OVERVIEW
                       FIGURE 41 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
             11.1.4 MEDTRONIC PLC
                       TABLE 148 MEDTRONIC PLC: BUSINESS OVERVIEW
                       FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
             11.1.5 B. BRAUN MELSUNGEN AG
                       TABLE 149 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
                       FIGURE 43 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
             11.1.6 BAXTER INTERNATIONAL INC.
                       TABLE 150 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
                       FIGURE 44 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)
             11.1.7 MÖLNLYCKE HEALTH CARE AB
                       TABLE 151 MÖLNLYCKE HEALTH CARE AB: BUSINESS OVERVIEW
                       FIGURE 45 MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2020)
             11.1.8 CONVATEC GROUP
                       TABLE 152 CONVATEC GROUP: BUSINESS OVERVIEW
                       FIGURE 46 CONVATEC GROUP: COMPANY SNAPSHOT (2020)
             11.1.9 PAUL HARTMANN AG
                       TABLE 153 PAUL HARTMANN AG: BUSINESS OVERVIEW
                       FIGURE 47 PAUL HARTMANN AG: COMPANY SNAPSHOT (2020)
               11.1.10 COLOPLAST A/S
                                   TABLE 154 COLOPLAST A/S: BUSINESS OVERVIEW
                                   FIGURE 48 COLOPLAST A/S: COMPANY SNAPSHOT (2020)
               11.1.11 ORGANOGENESIS HOLDINGS INC.
                                   TABLE 155 ORGANOGENESIS HOLDINGS INC.: BUSINESS OVERVIEW
                                   FIGURE 49 ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT (2020)
               11.1.12 MIMEDX GROUP
                                   TABLE 156 MIMEDX GROUP: BUSINESS OVERVIEW
                                   FIGURE 50 MIMEDX GROUP: COMPANY SNAPSHOT (2020)
               11.1.13 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
                                   TABLE 157 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
                                   FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
               11.1.14 MISONIX
                                   TABLE 158 MISONIX: BUSINESS OVERVIEW
                                   FIGURE 52 MISONIX: COMPANY SNAPSHOT (2019)
               11.1.15 ZIMMER BIOMET HOLDINGS INC.
                                   TABLE 159 ZIMMER BIOMET HOLDINGS INC.: BUSINESS OVERVIEW
                                   FIGURE 53 ZIMMER BIOMET HOLDINGS INC.: COMPANY SNAPSHOT (2020)
     11.2 OTHER PLAYERS
             11.2.1 ETHICON INC.
             11.2.2 DEROYAL INDUSTRIES
             11.2.3 KERECIS
             11.2.4 ACELL
             11.2.5 LOHMANN & RAUSCHER INTERNATIONAL GMBH & CO. KG
             11.2.6 MEDELA AG
             11.2.7 TALLEY GROUP
             11.2.8 WELCARE INDUSTRIES SPA
             11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
               11.2.10 PENSAR MEDICAL
               11.2.11 HAROMED BVBA
               11.2.12 DERMARITE INDUSTRIES LLC
               11.2.13 MEDLINE INDUSTRIES, INC.
               11.2.14 ADVANCIS MEDICAL LLC
               11.2.15 MIL LABORATORIES PVT. LTD.

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis and Right to Win might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 256)
     12.1 CASE STUDY ANALYSIS
             12.1.1 CASE STUDY 1
             12.1.2 CASE STUDY 2
     12.2 ADDITIONAL INSIGHTS
               TABLE 160 NORTH AMERICA: NEGATIVE PRESSURE INCISION MANAGEMENT MARKET, BY REGION, 2016–2023 (USD MILLION)
               TABLE 161 US: NEGATIVE PRESSURE INCISION MANAGEMENT MARKET, BY APPLICATION,  2016–2023 (USD MILLION)
     12.3 DISCUSSION GUIDE
     12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     12.5 AVAILABLE CUSTOMIZATIONS
     12.6 RELATED REPORTS
     12.7 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the wound care market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information and assess future prospects.

The following is a breakdown of the primary respondents:

Wound Care Market  Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the wound care market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research
  • The revenues generated by leading players operating in the wound care market have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Wound care market Size: Top Down Approach

Wound Care Market  Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the wound care market, by product, wound type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and trends)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of market segments with respect to four main regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the market and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as agreements, collaborations, partnerships, acquisitions, expansions, and product launches in the wound care market
  • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country Information

  • Wound care market size and growth rate estimates for counties in Rest of Europe, the Rest of Asia Pacific, and Rest of the World

Company Profiles

  • Additional five company profiles of players operating in the wound care market
COVID-19

Get in-depth analysis of the COVID-19 impact on the Wound Care Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Wound Care Market

Request For Special Pricing
Report Code
MD 2611
Published ON
Apr, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Wound Care Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved